ATRO vs RHI

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of just 2/9, indicating significant deterioration in core profitability and operational metrics. Despite strong recent earnings surprises and impressive short-term price momentum (+344.9% over 1Y), the company is unprofitable on a net basis (Profit Margin: -0.37%, ROE: -1.73%) and carries a dangerously high Debt/Equity ratio of 3.48. Valuation multiples are stretched (Forward P/E: 30.32, P/B: 24.85) relative to peers and lack support from sustainable earnings or cash flow visibility. Insider selling and lack of dividend strength further undermine confidence in long-term value preservation.

RHI exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health. The stock is significantly overvalued relative to its Graham Number ($19.38) and Intrinsic Value ($9.10), while trading at a prohibitive PEG ratio of 5.46. Revenue and earnings are in a clear downward trajectory, and the current dividend payout ratio of 181.76% is mathematically unsustainable. Technical trends are completely bearish (0/100), suggesting a lack of buyer conviction despite the high yield.